key: cord-0701754-u4udyl1u
authors: Bahramian, Aghil; Khoshnood, Saeed; Hashemi, Nader; Moradi, Melika; Karimi-Yazdi, Mohammadmahdi; Jalallou, Nahid; Saki, Morteza
title: Identification of metallo-β-lactamases and AmpC production among Escherichia coli strains isolated from hemodialysis patients with urinary tract infection
date: 2021-10-17
journal: Mol Biol Rep
DOI: 10.1007/s11033-021-06814-y
sha: b07bd0c78f6009eb6dd20dc00139c62a8e848798
doc_id: 701754
cord_uid: u4udyl1u

BACKGROUND: This study aimed to identify metallo-β-lactamases (MBLs) and AmpC β-lactamases-producing Escherichia coli isolates obtained from hemodialysis (HD) patients with urinary tract infections (UTI). METHODS AND RESULTS: A total of 257 HD patients with UTI were included in this study, from which 47 E. coli isolates were collected. Antibiotic susceptibility was tested by disc diffusion method. MBLs and AmpC production were phenotypically detected by imipenem-ethylenediaminetetracetate and cefoxitin/boronic acid assays, respectively. The presence of MBLs and AmpC genes was examined by polymerase chain reaction (PCR). Fosfomycin and ampicillin were the most and the least effective antibiotics against E. coli isolates, respectively. Moreover, 61.7% (29/47) of E. coli isolates were multidrug-resistant with seven different antibiotypes. Antibiotype V (AMP–CIP–IMP–MEM–CPD–CRO–CTX–GEN–LEV–SXT–TOB) was the most prevalent profile. Besides, 24 (51.1%) isolates were simultaneously resistant to imipenem and meropenem. Phenotypic assay showed MBL production in 16 (66.7%) of the 24 carbapenem-resistant E. coli isolates. The distribution of MBL genes in carbapenem-resistant E. coli was as follows: bla(IMP) 18 (72%), bla(VIM) 7 (28%), and bla(NDM) 1 (4%). AmpC was detected in 61.7% (29/47) of the isolates using the phenotypic method. The presence of AmpC genes was confirmed by PCR in only 26 of 29 (86.7%) AmpC producers. The frequencies of bla(DHA-1), bla(ACC), and bla(CMY-2) were 6 (20.7%), 11 (37.9%), and 21 (72.4%), respectively. CONCLUSIONS: The emergence of MBL and AmpC coproducing E. coli isolates calls for an urgent surveillance program for timely diagnosis and screening of these genes in our healthcare systems.

Dialysis is a procedure to remove excess fluids and waste products from the human body. There are two different methods of dialysis: peritoneal dialysis and hemodialysis (HD). The second method uses a machine located outside the body to remove blood and pump it into a dialyzer [1] . HD patients are at high risk for various infections, not only due to the invasiveness of this method, but also because of the immunosuppression caused by the inflammation and uremia [2] . In HD patients with chronic renal disease, infection is the leading cause of death. These patients are at risk of urinary tract infections (UTIs) which can lead to serious complications. Because of the problems in collecting urine samples from anuric or oliguric HD patients, UTIs are initially difficult to diagnose. Previous evidence suggests that multidrug-resistant bacterial

This descriptive cross-sectional study was conducted from October 2019 to July 2020. Written informed consent was obtained from all patients who participated in this study before the start of the work. A total of 257 HD patients with clinical suspicion of UTI (fever, chills, burning sensation during urination, cloudy urine, frequent and low urine output, unpleasant odor of urine) admitted to Army hospitals in Tehran city, were included in this study. The Army hospitals are located in Tehran, the capital of the country of Iran. These hospitals are for general referral and have all specialized and advanced medical departments. All patients with suspected UTI symptoms had their urine samples collected by clean-catch midstream protocol. A urine specimen was deemed positive for UTI if it contains a single microorganism with a count of ≥ 10 5 CFU/ml. E. coli isolates were identified by phenotypic and biochemical tests including Gram staining, lactose fermentation on MacConkey agar, triple sugar iron agar reaction, indole production, motility test, and Simmons' citrate test [14] . All culture media used in this study, were prepared and purchased from Merck Co, Germany.

AST was conducted using disc diffusion method, according to the recommendations of Clinical and Laboratory Standards Institute (CLSI) [15] . The AST was performed with the following antibiotic discs: imipenem (IMP, 10 μg), meropenem (MEM, 10 μg), amikacin (AMK, 30 μg), gentamicin (GEN, 10 μg), tobramycin (TOB, 10 μg), ampicillin (AMP, 10 μg), cotrimoxazole (SXT, 25 μg), fosfomycin (FOS, 10 μg), piperacillin-tazobactam (PTZ, 100/10 μg), ceftriaxone (CRO, 10 μg), ceftazidime (CAZ, 30 μg), cefpodoxime (CPD, 10 μg), cefotaxime (CXT, 30 μg), nitrofurantoin (NF, 300 μg), ciprofloxacin (CIP, 10 μg), and levofloxacin (LEV, 10 μg) (Mast, UK). E. coli ATCC 25922 was used as a control strain for the susceptibility tests. Isolates resistant to at least three classes of antibiotics were considered as MDR isolates.

The presence of MBLs was screened by the combined imipenem-ethylenediaminetetracetate (IMP-EDTA) disc test.

Briefly, isolates to be tested were inoculated on a Mueller Hinton Agar (Merck Co, Germany) plate using lawn culture method. One disc of IMP (10 μg) alone and another disc in combination with EDTA (750 μg/ml) were applied 20 mm apart and incubated for 18-24 h at 37ºC. Strains were confirmed as MBL producers once an increase of ≥7 mm in the inhibition zone of IMP-EDTA combination disc was observed compared to the IMP disc alone [16] .

The cefoxitin (FOX) disc (30 μg)/boronic acid was used to screen AmpC-producing isolates as previously described [17] . Isolates with the inhibition zones of <18 mm in diameter against FOX discs were considered potentially positive for AmpC screening and were subjected to further testing, using FOX disc alone and in combination with boronic acid (Sigma, USA). The presence of a 5-mm or larger increase in the inhibition zone diameter of the FOX disc in combination with boronic acid compared to the FOX alone, was considered as positive AmpC production.

The presence of AmpC genes (bla CMY-2 , bla DHA-1 , and bla ACC ) [18] and MBLs genes (bla IMP , bla VIM , and bla NDM ) [19] was detected by polymerase chain reaction (PCR). Genomic DNA extraction was performed using the boiling method [20] . The PCR was performed in a final volume of 25 μl consisting of DNA template (50 ng), dNTPs (100 μM), Taq buffer (5×), Taq DNA polymerase (1 U; Cinnagen, Iran), and forward and reverse primers (25 pM each). The PCR mixtures were subjected to thermal cycling. PCR reactions included 30 amplification cycles in a Mastercycler (Eppendorf, Germany) under the following conditions: denaturation at 95 °C/5 min, annealing at 55 °C/30 s, and extension at 72 °C/45 s, with a final extension at 72 °C/6 min. Amplified products were visualized using electrophoresis on a 1% agarose gel stained with safe stain (Sinaclon, Iran), in a Tris-Borate-EDTA buffer (Promega, USA). Water was used as a negative control in the study, and the positive controls were K.pneumoniae ATCC 700603, P.aeruginosa ATCC 27853, P.aeruginosa ST 147, K.pneumoniae KP696465, E.coli KX 342010 and E.coli KX342011.

Data were entered and statistically analyzed using Microsoft Excel 2019 (Microsoft Corporation, USA) and the Statistical Package for the Social Sciences (SPSS) software version 22 (IBM SPSS Statistics, USA) [21] . The results were presented as descriptive statistics in the form of relative frequency.

In this study, a total of 47 E. coli isolates were obtained from urine samples of HD patients, with an overall prevalence of 18.3% (47/257). The isolates were obtained from 21 (44.7%) males and 26 (55.3%) females (female/male ratio =1.23), respectively. The mean age of the patients was (31 ± 1) years, and ranged from 2 to 65 years. The E. coli isolates showed the highest susceptibility (87.2%) and esistance (100%) to FOS and AMP antibiotics, respectively. PTZ and NF were the second and third most effective antibiotics, respectively. More than 70% of the isolates were resistant against third-generation cephalosporin (TGC) antibiotics. As well, 24 (51.1%) isolates were simultaneously resistant to IMP and MEM. The susceptibility rate results for all antibiotics tested are shown in Table 1 . The results of AST showed that 61.7% (29/47) of E. coli isolates were MDR with seven different antibiotypes ( Table 2) . Antibiotype V (AMP-CIP-IMP-MEM-CPD-CRO-CTX-GEN-LEV-SXT-TOB) was the most prevalent profile (31.0%).

The results of the IMP-EDTA combined disc test confirmed the MBL production in 16 (66.7%) out of 24 carbapenem-resistant E. coli isolates. PCR results showed that all 24 carbapenem-resistant E. coli isolates had at least one MBL gene. The distribution of MBL genes among Table 3 ). The electrophoresis image of some MBL and AmpC positive isolates is shown in Fig. 1 .

At present, a paucity of epidemiological information is available on E. coli strains causing UTIs, as well as on their antibiotic resistance profiles and resistance mechanisms in HD patients from many countries including Iran. The novelty of this study was to address these issues in a region of Iran. The present study investigated the prevalence and antibiotype patterns of UTI-causing E. coli isolates in HD patients against 16 antibiotics. The results showed an overall prevalence of 18.3% for UTI-causing E. coli isolates in HD patients. This rate was much lower than the rate (43%) reported by Sadeghi et al. [22] from Isfahan, Iran, but in kidney transplant patients. In another research in USA, a frequency rate of 29.3% was reported for E. coli isolates in HD patients [23] . The rationale behind these discrepancies is likely the differences in studied population, patient screening programs, and predominant pattern of UTI-inducing pathogens in each region.

According to the results of AST, MEM and IMP were among the relatively least effective antibiotics, with resistance rates of about 50%. These results were in contradiction with previous reports by Critchley et al. [24] from USA, Raeispour et al. [25] from Iran, and Duicu et al. [26] from Romania who showed the efficacy of more than 90% for these two antibiotics. The emergence of carbapenemresistant Gram-negative bacteria in recent years has posed a new challenge to medical centers, both in Iran and other parts of the world [27, 28] . This phenomenon may arise from the high prevalence of different carbapenemase genes that can develop resistance to carbapenem antibiotics [28] . Although FOS was the most effective antibiotic, its resistance rate (12.8%) was higher than the rate reported in South Korea (6.7%) [29] .

Of the three aminoglycosides studied here, AMK showed the highest efficacy compared to GEN and TOB, supporting previous studies from USA [24] and Gabon [30] . However, a survey by Kushwaha et al. [31] from Nepal showed an opposite result: GEN had higher efficacy against UTI-inducing E. coli isolates than AMK and TOB. In this study, more than half of the E. coli isolates were resistant to GEN and TOB, which was higher than the report of Naziri et al. [32] from Iran.

This higher resistance rate could be explained by the excessive parenteral administration of these antibiotics in our region. Our study explored a high resistance rate, ranging from 72.3 to 85.1%, against TGC antibiotics, which was in agreement with previous researches conducted by Raeispour et al. [25] and Lee et al. [33] , but in contrast to findings achieved from USA [24] and Gabon [30] . The high resistance rates against TGCs is possibly rooted in increasing the spread of extended-spectrum β-lactamase genes in UTI pathogens in Iran and other countries during recent decades, which were not investigated in the current study [34, 35] . 

The resistance rates against CIP and LEV were 61.7% and 38.3%, respectively. Reports from Iran by Halaji et al. [34] and Raeispour et al. [25] stated the resistance rates of 54.3% and 34% for CIP, respectively. These rates were lower than those of the current study. The administration of CIP, as the first-line therapy, against UTI-inducing bacteria might be the reason for this higher resistance rate. Another finding obtained in the present work was the exceptional efficacy of NF with a susceptibility rate of 76.6%.

In line with our result, Lee et al. [33] reflected the high susceptibility rates (74.3%-100%) of NF against different UTI-inducing bacteria and stated that 99.2% of E. coli isolates were NF-susceptible. Similarly, Raeispour et al. [23] implied that 90% of UTI-inducing E. coli isolates were susceptible to this antibiotic, as well. In another study in Gabon, which was comparable with ours, Mouanga Ndzime et al. [30] identified NF as the most effective drug against UTIinducing E. coli isolates.

Likewise, a high proportion (80.9%) of E. coli isolates were susceptible to PTZ, confirming the results observed by Critchley et al. [24] in the USA and Halaji et al. [34] in Iran. In this study, AMP and SXT (with resistance rates of 100% and 80.9%, respectively) were among the less effective antibiotics, a result consistent with those observed in the Gabon [30] , USA [24] , and Iran [34] .

This result for AMP was not far-fetched because in recent years, many Gram-negative bacilli carrying β-lactamase enzymes have readily become resistant to a wide range of β-lactam antibiotics. As SXT has always been one of the first-line drugs for the treatment of UTIs, according to the observed evidence, it is recommended to prescribe this drug with regard to the results of antibiotic susceptibility tests.

One notable finding of this study was the relatively high prevalence of MDR (61.7%) E. coli isolates. Previous studies have reported various MDR frequencies, ranging from 55.1 to 100% for UTI-causing E. coli isolates [25, 30, 34] . In this study, 7 different antibiotypes were seen in MDR isolates. Previous study from Saudi Arabia showed 70 different antibiotypes in E. coli isolates collected from clinical samples [36] . In another study by Alanazi et al. [37] , 7 different antibiotypes were seen in UTI-causing E. coli isolates against ciprofloxacin, ampicillin and co-trimoxazole antibiotics. In this study, according to the results of the antibiogram, the most effective antibiotic against these MDR isolates was the FOS that can be considered for treatment of the MDR UTI-causing E. coli. These results necessitate the development of a surveillance program for antibiotic consumption to control the spread of MDR E. coli isolates in healthcare systems of our country. In recent years, the outbreak of E. coli sequence type 131 (ST131) isolated from urine culture has become one of the global health problems due to the high prevalence of multidrug resistance. This clone has a wide range of virulence factors including siderophores, adhesins, and toxins which disrupt host defense mechanisms. The majority of these factors are found on mobile genetic elements (MGEs) or pathogenicity islands (PAI), which are capable of being horizontally transmitted among different species [38, 39] . MGEs have a huge impact on bacterial genomes, including causing marked differences in genome size and pathogenicity. Although bacteria have several mechanisms for resisting lateral gene transfer, MGEs play a major role in bacterial evolution and contribute greatly to adaptation to new and changing ecological niches. Most of the resistance genes are acquired by horizontal transfer of plasmids and other MGEs, and this process has been associated with the successful dissemination of particular lineages. Also, MGEs have an important role in virulence gene acquisition and forming new subpopulations among pandemic clones such as E. coli ST131 [38, 39] . This study investigated the production of MBL and AmpC β-lactamases in UTI-inducing E. coli isolates in HD patients. To the best of our knowledge, this was the first study in this regard in Iran. Today, there are multiple phenotypic methods for detecting β-lactamases, but owing to the multiplicity of different types of these enzymes, none of the phenotypic methods can identify all types. Therefore, their detection is mostly based on molecular methods such as PCR or real-time PCR [40, 41] .

In our survey, AmpC and MBL phenotypes were detected in 29 (61.7%) and 16 (34%) UTI-causing E. coli isolates, respectively. Similar to these results, Helmy et al. [42] reported a prevalence of 66.6% for AmpC-producing E. coli isolates in Egyptian UTI patients using phenylboronic acid method. A higher prevalence rate (87.5%, n = 175/200) was also reported for the detection of phenotypic AmpC in UTI-inducing E. coli isolates collected from New Zealand by Drinkovic et al. [43] . In opposition to our findings, Jamil et al. [44] stated a lower frequency (16%, n = 12/75) of UTIcausing E. coli isolates harboring MBLs in Pakistan using phenotypic method. Variations in the results seem to arise from differences in the phenotypic test methods, quality of materials used, and dissimilarity in geographical area.

The results of PCR assay revealed a frequency of 20.7%, 37.9%, and 72.4% for bla DHA-1 , bla ACC , and bla CMY-2 AmpC β-lactamases-producing isolates, respectively. In conformity with our results, findings by Helmy et al. [42] from Egypt and Drinkovic et al. [43] from New Zealand represented the bla CMY-2 (89% [n = 90/101]) as the predominant type of AmpC in UTI-inducing E. coli isolates. The extensive dissemination of bla CMY-2 among E. coli isolates could be linked to unique transposon-like element ISEcp1, which is thought to play a role in the transmission of bla CMY -2 from the Citrobacter freundii chromosome to other Enterobacteriaceae [42] . In another study conducted in Egypt, the prevalence rate of 50% was reported for bla DHA AmpC in UTI-causing E. coli, while other AmpC genes were not detected [45] . In a study from Nepal, two AmpC genes bla CIT and bla DHA were detected in 30.6% and 31.3% of clinical E. coli isolates, respectively [46] . Another experiment by Shayan and Bokaeian [47] , showed a prevalence of 5.0% and 0.0% for bla CMY-2 and bla FOX genes, respectively. They did not investigate the remaining AmpC genes. In a recent study from Iran, no bla MOX and bla ECC genes were found in uropathogenic E. coli isolates, while, bla CIT , bla FOX , bla DHA , and bla EBC were detected in 73.6%, 10.5%, 10.5%, and 15.8% of E. coli isolates, respectively [48] . Currently, the clinical microbiology laboratories do not have a reliable method of detecting and confirming AmpC β-lactamases. For this reason, the molecular characterization of β-lactamases, in particular the AmpC family, is of crucial importance in in terms of molecular epidemiology and genetic contributing factors [48] .

This study revealed the high prevalence rate of MBL genes in 24 carbapenem-resistant isolates, as all of them harbored at least one MBL gene. In the current study, the bla IMP (72%) was the most prevalent MBL gene followed by bla VIM (28%) and bla NDM (4%). The emergence of MBL-producing UTI-inducing E. coli isolates could be considered a serious threat to health communities because this pathogen is resistant to numerous antibiotics. In a study by Naeem et al. [49] , the NDM-positive rate was 38.5% (n = 10/26) among E. coli strains isolated from urine samples that was higher than the current result. In another study from Sudan [50] , the bla VIM (16.7%) was the most prevalent MBL gene in clinical E. coli isolates followed by bla IMP (8.3%) and bla NDM (2.8%).There is a paucity of data regarding the bla VIM and bla IMP harboring UTI-causing E. coli in Iran. In a recent study from southwest Iran, each of bla IMP-1 and bla IMP-2 genes were detected in 8.3% of uropathogeneic E. coli isolates, while the bla NDM was detected in 75.0% of isolates. Also, the bla VIM-1 and bla VIM-2 were not detected [51] . In another study by Deldar Abad Paskeh et al. [52] from Iran, a lower occurrence rates of bla IMP (8.7%) and bla VIM (9.8%) genes were reported in UTI-causing E. coli compared to the current study. In a recent study from Taiwan, an increasing rate of NDM-positive E. coli isolates has been reported in clinical samples. They reported a prevalence rates of 39.1%, 30.4%, 21.7%, and 8.7% for NDM, IMP-8, KPC-2, and VIM-1, respectively [53] . NDM is a member of the amber class B β-lactamases, which can hydrolyze virtually all β-lactams except monobactam [53] . In China and its neighboring countries, IncX3 plasmids are the most common types of plasmids carrying bla NDM in Enterobacteriaceae [54] , while in a recent study from Iran, bla NDM-1 gene was located on both conjugative plasmids: IncFII ∼86-kb to ∼140-kb and IncA/C [55] . There are various classes of chromosomal and plasmidic MBLs including Sao Paulo metallo-β-lactamase (SPM), German imipenemase (GIM), and Adelaide imipenemase (AIM) that were not screened in this study and could pave the way for further epidemiological research in the future [56] .

The present research showed that 38.3% of the isolates harbored both MBL and AmpC genes simultaneously. In this regard, co-occurrence of β-lactamase genes has been reported in several investigations [45, 57] , which was in harmony with the results of this study. In recent years, the occurrence of different β-lactamases in various Gram-negative bacteria has been reported in various studies [58] [59] [60] [61] . Due to the financial and traffic constraints caused by the COVID-19 virus pandemic, the current study has the following limitations: the lack of MBLs and AmpC genes sequencing, the lack of antibiogram results for some newer and reserved antibiotics including ceftazidime/avibactam, imipenem/relebactam, ceftolozane/tazobactam, colistin, and tigecycline, and lack of evaluation of other bacteria contributed to UTI in HD patients. Also, due to the non-shareable privacy of those patients referred to Army hospitals, we did not have any clinical data of individuals to evaluate the correlation of infections by MDR E. coli in HD patients with other important predisposing conditions to detect if any significant trends exist in the prevalence of such MDR strains among different susceptible groups.

This survey portrayed the high resistance rates of UTIcausing E. coli isolates harboring AmpC and MBLs in HD patients against AMP, SXT, and TGCs. In light of this information, it is recommended to choose treatments based on the antibiogram results, in order to hinder the further spread of MDR isolates. Moreover, the higher efficacy of FOS, PTZ and NF against UTI-inducing E. coli isolates, compared to other antibiotics, made them suitable options for empirical therapy. The emergence of MBL and AmpC co-producing E. coli isolates calls for an urgent surveillance program for timely diagnosis and screening of these genes in our healthcare systems. In future, such program can be of great help in preventing the spread of antibiotic resistance in our country, Iran. Another suggestion is to evaluate the other infections and their etiological pathogens such as septicemia in HD patients to prepare a suitable epidemiological data bank in this regard in Iran.

Urinary tract infection in hemodialysis patients with renal failure

Colonization and risk of infection by multidrug-resistant bacteria in hemodialysis patients: a topic of concern

Treatment of recurrent urinary tract infections in anuric hemodialysis patient, do we really need antimicrobial urinary concentration? ID Cases

Prevalence and antibiogram of MDR E. coli strains isolated from UTI patients-1-Year retrospective study at Nishtar medical hospital

Prevalence of urinary tract infection in both outpatient department and in patient department at a medical college setting of Bangladesh

Population-based linkage of health records to detect urological complications and hospitalisation following transrectal ultrasound-guided biopsies in men suspected of prostate cancer

Prevalence and antibiotic resistance pattern of Escherichia coli and Klebsiella pneumoniae in urine tract infections at the La Paz Medical center

Frequency and antimicrobial resistance patterns of bacteria implicated in community urinary tract infections: a ten-year surveillance study

Prevalence and antibiotic resistance pattern of extended spectrum beta lactamase producing Escherichia coli isolated from urinary tract infection

Prevalence and antibiotic susceptibility pattern of E. coli isolated from urinary tract infection in patients with renal failure disease and renal transplant recipients

Prevalence of extended spectrum β-lactamase, AmpC β-lactamase and metallo β-lactamase mediated resistance in Escherichia coli from diagnostic and tertiary healthcare centers in south Bangalore, India

AmpC and metallo betalactamases producing Gram negative bacteria in patients with hematological malignancy

Detection of plasmid-mediated AmpC β-lactamase genes in clinical isolates by using multiplex PCR

Studies on drug sensitivity and bacterial prevalence of UTI in tribal population of paschim Medinipur

Performance standard for antimicrobial susceptibility testing; seventeenth informational supplement. CLSI Document M100_s19

Evaluation of different laboratory tests for the detection of metallo-β-lactamase production in Enterobacteriaceae

Occurrence of extended-spectrum and AmpC beta-lactamases in bloodstream isolates of Klebsiella pneumoniae: isolates harbor plasmid-mediated FOX-5 and ACT-1 AmpC beta-lactamases

Characterization of CMY-2-type beta-lactamase-producing Escherichia coli isolated from chicken carcasses and human infection in a city of South Brazil

Detection of carbapenem-resistant genes in Escherichia coli isolated from drinking water in Khartoum Sudan

Identification of extended-spectrum β-lactamase genes and ampc-β-lactamase in clinical isolates of Escherichia coli recovered from patients with urinary tract infections in Kerman. Iran

Detection of Helicobacter Pylori infection by invasive and non-invasive techniques in patients with gastrointestinal diseases from Iraq: A validation study

Characterization of plasmid-mediated quinolone resistance and serogroup distributions of uropathogenic Escherichia coli among Iranian kidney transplant patients

Isolation rate and clinical significance of uropathogens in positive urine cultures of hemodialysis patients

The burden of antimicrobial resistance among urinary tract isolates of Escherichia coli in the United States in 2017

Antibiotic resistance, virulence factors and genotyping of Uropathogenic Escherichia coli strains

Antibiotic resistance patterns of urinary tract pathogens in children from Central Romania

Systematic review and meta-analysis of carbapenem resistance of Acinetobacter baumannii in Iran

Infections caused by carbapenem-resistant Enterobacteriaceae: an update on therapeutic options

Fosfomycin resistance in Escherichia coli isolates from South Korea and in vitro activity of fosfomycin alone and in combination with other antibiotics

Epidemiology of community origin Escherichia coli and Klebsiella pneumoniae uropathogenic strains resistant to antibiotics in Franceville

Antibiotic resistance to Escherichia coli among urine culture-positive patients in a tertiary care hospital in Nepal: A descriptive cross-sectional Study

Treatment failure in urinary tract infections: a warning witness for virulent multi-drug resistant ESBL-producing Escherichia coli

Urinary tract infections in pregnancy in a rural population of Bangladesh: population-based prevalence, risk factors, etiology, and antibiotic resistance

Characterization of extended-spectrum β-lactamaseproducing uropathogenic Escherichia coli among Iranian kidney transplant patients

Risk factors for community acquired urinary tract infections caused by extended spectrum beta-lactamase (ESBL) producing Escherichia coli in children: a case control study

Molecular characterization, antimicrobial resistance and clinico-bioinformatics approaches to address the problem of extended-spectrum β-lactamase-producing Escherichia coli in western Saudi Arabia

An evaluation of E. coli in urinary tract infection in emergency department at KAMC in Riyadh, Saudi Arabia: retrospective study

Virulence and resistance properties of E. coli isolated from urine samples of hospitalized patients in Rio de Janeiro, Brazil-The role of mobile genetic elements

Arrangements of mobile genetic elements among virotype E subpopulation of Escherichia coli sequence type 131 strains with high antimicrobial resistance and virulence gene Content

Distribution of Class B and Class A β-lactamases in clinical strains of Pseudomonas aeruginosa: comparison of phenotypic methods and high-resolution melting analysis (HRMA) assay

Distribution of carbapenemase genes in clinical isolates of Acinetobacter baumannii and a comparison of MALDI-TOF mass spectrometrybased detection of carbapenemase production with other phenotypic methods

Phenotypic and molecular characterization of plasmid mediated AmpC β-lactamases among Escherichia coli, Klebsiella spp, and Proteus mirabilis isolated from urinary tract infections in Egyptian hospitals

Plasmid-mediated AmpC beta-lactamase-producing Escherichia coli causing urinary tract infection in the Auckland community likely to be resistant to commonly prescribed antimicrobials

Prevalence, antibiotic sensitivity and phenotypic screening of ESBL/ MBL producer E. coli strains isolated from urine; District Swabi

Prevalence and molecular characteristics of ESBL and AmpC β-lactamase producing Enterobacteriaceae strains isolated from UTIs in Egypt

Plasmid-mediated AmpC β-lactamase CITM and DHAM genes among gram-negative clinical isolates

Detection of ESBL-and AmpCproducing E. coli isolates from urinary tract infections

Clonal relationship and resistance profiles among ESBL-producing Escherichia coli

Detection of bla NDM-1 gene in ESBL producing Escherichia coli and Klebsiella pneumoniae isolated from urine samples

Prevalence of metallo-β-lactamase acquired genes among carbapenems susceptible and resistant Gram-negative clinical isolates using multiplex PCR, Khartoum hospitals

Virulence characterization and clonal analysis of uropathogenic Escherichia coli metallo-beta-lactamaseproducing isolates

Prevalence of plasmid-encoded carbapenemases in multidrug resistant Escherichia coli from patients with urinary tract infection in northern Iran

Increasing New Delhi metallo-β-lactamase-positive Escherichia coli among carbapenem non-susceptible Enterobacteriaceae in Taiwan during

NDM metallo-β-lactamases and their bacterial producers in health care settings

Molecular epidemiology of OXA-48 and NDM-1 producing enterobacterales species at a University Hospital in Tehran

Metallo-β-lactamases: structure, function, epidemiology, treatment options, and the development pipeline

Phenotypic and molecular characterization of β-lactamases among enterobacterial uropathogens in Southeastern Nigeria

DNA sequence analysis of bla VEB gene encoding multi-drug resistant and extended-spectrum β-lactamases producer isolates of Enterobacteriaceae and Pseudomonas aeruginosa

Molecular Screening of Ambler class C and extended-spectrum β-lactamases in multi-drug resistant Pseudomonas aeruginosa and selected species of Enterobacteriaceae

Molecular detection and sequencing of SHV gene encoding for extended-spectrum β-lactamases produced by multidrug resistance some of the Gramnegative bacteria

Identification of an OprD and bla IMP gene-mediated carbapenem resistance in Acinetobacter baumannii and Pseudomonas aeruginosa among patients with wound infections in Iraq

We gratefully acknowledge AJA University of Medical Sciences, Tehran, Iran for supporting this study.